Stereotaxis, Inc. (STXS)
NYSEAMERICAN: STXS · Real-Time Price · USD
2.640
-0.040 (-1.49%)
Jan 20, 2026, 4:00 PM EST - Market closed
Stereotaxis Market Cap
Stereotaxis has a market cap or net worth of $246.38 million as of January 21, 2026. Its market cap has increased by 27.00% in one year.
Market Cap
246.38M
Enterprise Value
241.45M
1-Year Change
27.00%
Ranking
Category
Stock Price
$2.64
Market Cap Chart
Since August 12, 2004, Stereotaxis's market cap has increased from $183.10M to $246.38M, an increase of 34.56%. That is a compound annual growth rate of 1.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 246.40M | 14.82% |
| Dec 31, 2025 | 214.60M | 11.08% |
| Dec 31, 2024 | 193.20M | 36.54% |
| Dec 29, 2023 | 141.50M | -8.65% |
| Dec 30, 2022 | 154.90M | -66.50% |
| Dec 31, 2021 | 462.40M | 23.27% |
| Dec 31, 2020 | 375.10M | 6.26% |
| Dec 31, 2019 | 353.00M | 474.92% |
| Dec 31, 2018 | 61.40M | 237.36% |
| Dec 29, 2017 | 18.20M | 28.17% |
| Dec 30, 2016 | 14.20M | -10.69% |
| Dec 31, 2015 | 15.90M | -47.52% |
| Dec 31, 2014 | 30.30M | -47.49% |
| Dec 31, 2013 | 57.70M | 215.30% |
| Dec 31, 2012 | 18.30M | -55.90% |
| Dec 30, 2011 | 41.50M | -76.45% |
| Dec 31, 2010 | 176.20M | -2.22% |
| Dec 31, 2009 | 180.20M | 19.97% |
| Dec 31, 2008 | 150.20M | -63.64% |
| Dec 31, 2007 | 413.10M | 27.11% |
| Dec 29, 2006 | 325.00M | 49.56% |
| Dec 30, 2005 | 217.30M | 991.96% |
| Dec 31, 2004 | 19.90M | -89.13% |
| Aug 12, 2004 | 183.10M | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |